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أدلة على وجود اختالل مبكر يف وظيفة القلب االنبساطية باستخدام ختطيط 
القلب عند األطفال املصابني مبرض تكون العظم الناقص
خلفان �سامل ال�سنيدي، عرفان اهلل، ها�سم جواد، مرت�سى اخلابوري، �سيف اليعربي
abstract: Objectives: Structural and functional cardiovascular abnormalities have been reported in adults with 
osteogenesis imperfecta (OI); however, there is a lack of paediatric literature on this topic. This study aimed to 
investigate cardiovascular abnormalities in children with OI in comparison to a control group. Methods: This 
case-control study was conducted at the Sultan Qaboos University Hospital in Muscat, Oman, between May 2013 
and August 2014. Data from eight patients with OI and 24 healthy controls were compared using conventional and 
tissue Doppler echocardiography (TDE). Results: The OI group had significantly lower peak early mitral valve flow 
velocity (P = 0.027), peak a-wave reversal in the pulmonary vein (P = 0.030) and peak early diastolic velocity of the 
mitral valve and upper septum (P = 0.001 each). The peak late diastolic velocities of the mitral valve (P = 0.002) 
and the upper septum (P = 0.037) were significantly higher in the OI group; however, the peak early/late diastolic 
velocity ratios of the mitral valve (P = 0.002) and upper septum (P = 0.001) were significantly lower. Left ventricular 
dimensions and aortic and pulmonary artery diameters were larger in the OI group when indexed for body surface 
area. Both groups had normal systolic cardiac function. Conclusion: Children with OI had normal systolic cardiac 
function. However, changes in myocardial tissue Doppler velocities were suggestive of early diastolic cardiac 
dysfunction. They also had increased left ventricular dimensions and greater vessel diameters. These findings 
indicate the need for early and detailed structural and functional echocardiographic assessment and follow-up of 
young patients with OI.
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امللخ�ص: الهدف: اأظهرت الدرا�سات العلمية وجود اختاللت تكوينية ووظيفية يف القلب والأوعية الدموية يف البالغني الذين يعانون من مر�ض تكون العظم 
الناق�ض )OI( اإل اأن هناك نق�ض يف الدرا�سات املتعلقة بهذا املر�ض عند الأطفال. الطريقة: هدفت هذه الدرا�سة اإىل التحقق من مدى وجود 
اختاللت يف القلب والأوعية الدموية لدى الأطفال امل�سابني بهذا املر�ض باملقارنة مع جمموعة املراقبة. الطريقة: اأجريت هذه الدرا�سة  يف 
م�ست�سفى جامعة ال�سلطان قابو�ض يف م�سقط، عمان، بني مايو 2013 واأغ�سط�ض 2014 حيث متت مقارنة بيانات اأ�سعة �سدى القلب التكوينية 
والوظيفية بني 8 مر�سى م�سابني مبر�ض تكون العظم الناق�ض و 24 حالة من جمموعة املراقبة ال�سليمة. النتائج: بينت الدرا�سة اأن مر�سى 
تكون العظم الناق�ض لديهم قيا�سات اأقل بكثري من جمموعة املقارنة لذروة �رسعة التدفق املبكر لل�سمام التاجي )P = 0.027( وذروة موجة 
الرتاجع يف الوريد الرئوي )P = 0.030( وذروة ال�رسعة النب�ساطية املبكرة لل�سمام التاجي واحلاجز العلوي )P = 0.001 لكل منهما(. وكانت 
ذروة ال�رسعة النب�ساطية املتاأخرة لل�سمام التاجي )P = 0.002( واحلاجز العلوي )P = 0.037( اأعلى بكثري يف جمموعة مر�سى تكون العظم 
 )P = 0.001( واحلاجز العلوي )P = 0.002( الناق�ض؛ ومع ذلك، فاإن ن�سبة الذروة يف ال�رسعة النب�ساطية املبكرة/املتاأخرة لل�سمام التاجي
كانت اأقل من جمموعة املقارنة بكثري. اأي�سا كانت اأبعاد البطني الأي�رس واأقطار ال�رسيان الأبهر و الرئوي اأكرب يف جمموعة مر�سى تكون 
العظم الناق�ض عندما مت فهر�ستها مل�ساحة �سطح اجل�سم. وبينت الدرا�سة كذلك اأن وظيفة القلب النقبا�سية لكال الفريقني ذات معدل طبيعي. 
اخلال�صة: بينت الدرا�سة اأن وظيفة القلب النقبا�سية لدى الأطفال امل�سابني مبر�ض تكون العظم الناق�ض ذات معدل طبيعي اإل اأنه توجد 
تغريات ب�سيطة توحي بوجود خلل اأّويل يف وظائف القلب النب�ساطية. كما اأنها بينت عن وجود زيادة اأبعاد البطني الأي�رس وكذلك كرب حجم 
الأوعية الدموية الرئي�سية. هذه النتائج ت�سري اإىل احلاجة اإىل التقييم املبكر واملتابعة امل�ستمرة للمر�سى ال�سغار امل�سابني مبر�ض تكون 
العظم الناق�ض بتخطيط �سدى القلب الوظيفي.
مفتاح الكلمات: الأطفال؛ مر�ض تكون العظم الناق�ض؛ ت�سوهات القلب والأوعية الدموية؛ دوبلر �سدى القلب.
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Advances in Knowledge
- This study highlights for the first time early changes in the myocardial tissue Doppler velocities of a group of children with osteogenesis 
imperfecta (OI). These changes suggest the early development of diastolic cardiac dysfunction and preservation of systolic cardiac 
function in young patients with this genetic disorder.
Application to Patient Care
- Cardiovascular assessment of children with OI provides important additional information to support management of this disease. 
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Previously, physicians focused primarily on skeletal malformation and structural and systolic cardiac function; however, with the 
availability of non-invasive echocardiographic tests, this focus can be extended to diastolic function.
- Early and newer therapeutic modalities could help treat or modify the progression of OI. This could prevent further deterioration of 
cardiac function. Early intervention is essential considering the tendency for this group of patients to be limited in their activities and in 
sports when they reach adulthood. 
Osteogenesis imperfecta (oi) is a group of autosomal disorders of the connective tissues and is commonly caused by 
mutations in genes encoding the α-1 and α-2 chains 
of type 1 collagen or proteins involved in the post-
translational modification of type 1 collagen.1 OI is 
characterised by various skeletal and extraskeletal 
manifestations.2 The disease has considerable clinical 
and biochemical heterogeneity between and within 
different patients. Common clinical manifestations 
of this disease are well-known and include blue 
sclera, brittle bones, conductive hearing defects and 
dental abnormalities.2 
Tissue Doppler echocardiography (TDE) offers a 
non-invasive quantitative method of assessing longi-
tudinal systolic and diastolic ventricular performance 
by measuring velocities directly from the myocar-
dium.3–5 While a few studies have described cardio-
vascular involvement among adults with OI, there is 
very little data available for paediatric patients.6,7 To 
the best of the authors’ knowledge, this is the first study 
assessing cardiovascular abnormalities, particularly 
systolic and diastolic function, in paediatric patients 
with OI using both conventional and TDE techniques.
Methods
This case-control study was conducted at the Sultan 
Qaboos University Hospital (SQUH) in Muscat, 
Oman, between May 2013 and August 2014. All 
patients diagnosed with OI and followed-up at SQUH 
during the study period were enrolled in the study. 
The diagnosis of OI was based on the classification 
developed by Sillence et al.8 Age- and gender-matched 
healthy children were included in the study as the 
control group. The selected controls were either 
healthy volunteers or had been referred to the clinic 
because of heart murmurs which were later found to 
be innocent. A detailed medical history was recorded 
for each subject, including any existing comorbidities. 
Anthropometric and physical examinations were 
performed and heart rates were measured for all 
participants. Routine complete blood count tests, 
12-lead electrocardiography, two-dimensional 
Doppler echocardiography and pulse TDE were 
performed on all of the subjects during routine visits 
to the hospital. Blood pressure was measured in the 
right arm with an age-appropriate cuff size. 
Systolic and diastolic cardiac function was assessed 
using conventional and TDE techniques. Two-
dimensional echocardiography was performed using 
an ultrasound echocardiography machine (Vivid E9, 
GE Vingmed Ultrasound AS, Horten, Norway) while 
the subjects were at rest. Motion (M)-mode, two-
dimensional Doppler echocardiography and pulse TDE 
data were collected by a qualified echocardiographer. 
The subjects were fully awake during the procedure 
according to the recommendations of the American 
Society of Echocardiography.9 
The left ventricular end systolic (LVISd) and 
diastolic (LVIDd) dimensions, as well as the septal 
(IVSd) and left ventricular posterior wall thickness 
in diastole (LVPWd) were assessed using M-mode 
from the parasternal long axis view. Subsequently, 
the shortening fraction (SF) and ejection fraction 
(EF) were determined.9 Using the left parasternal 
long axis view, the aortic annulus (AoAn), sinus of 
Valsalva (SinVals), sinotubular junction (Sintubj) and 
ascending aorta (AscAo) diameters were measured. 
From the parasternal high short axis view, diameter 
measurements of the pulmonary valve annulus 
(PVAn), main pulmonary artery (MPA) and left 
(LPA) and right (RPA) pulmonary arteries were taken. 
The early (Em) and late (Am) peak velocities of the 
mitral valve inflow, deceleration time of the Em wave 
(DTm) and Am wave duration were measured from 
the four chamber view with placement of the pulse 
Doppler sample volume at the tips of the valve leaflets. 
Isovolumic relaxation time (IVRT) was measured by 
placing the continuous Doppler sample volume in 
the left ventricular outflow tract in the three chamber 
view. Assessment of the right upper pulmonary vein 
pulse Doppler pattern was taken from a four chamber 
view to measure the systolic (Spv), diastolic (Dpv) 
and a-wave reversal peak velocity (Apv) and duration 
(Apvd). The Spv/Dpv ratio and the mitral valve inflow 
late velocity duration and a-wave duration ratio of the 
pulmonary veins (Amd/Apvd) were obtained. 
TDE was performed by placing the sample volume 
at the corner of the mitral annulus, the upper part 
of the interventricular septum and the corner of the 
tricuspid valve in the four chamber view. In each 
region, the systolic (S’) wave, early diastolic (E’) and 
late diastolic (A’) velocities were recorded and the 
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Em/peak early diastolic velocity of the mitral valve 
(E’m) ratio was obtained. Global systolic myocardial 
function was evaluated by EF and SF using M-mode in 
addition to the peak systolic velocities (S’) of the TDE. 
In the early stages of diastolic dysfunction, impaired 
relaxation and passive filling of the left ventricle 
predominates, resulting in a low Em and E’m, high Am 
and peak late diastolic velocity of the mitral valve (A’m) 
and low Em/Am and E’m/A’m ratios.10 Another reliable 
indicator of diastolic dysfunction is a high Em/E’m 
ratio, which is an estimate of the filling pressure of the 
left ventricle.11 Assessment of pulmonary hypertension 
was performed by measuring the maximum velocity 
of the tricuspid valve regurgitation jet, if present, 
as well as the pulmonary valve regurgitation peak 
velocity. The Z score was calculated for AoAn, SinVals, 
Sintubj, PVAn, MPA, RPA, LPA and left ventricular 
dimensions.12 All measurements reported in this study 
represent the average value of at least three cardiac 
cycles per subject.
Statistical analysis of the data was performed using 
the Statistical Package for the Social Sciences (SPSS), 
Version 20.0 (IBM Corp., Chicago, Illinois, USA). All 
results were expressed as means ± standard deviation. 
The independent Student’s t-test and Mann-Whitney 
U test were used when appropriate. A multivariate 
linear regression was used to find the impact of 
baseline differences between the two groups, including 
the diagnosis of OI. Differences were considered 
statistically significant at P <0.050. 
This study was approved by the Medical Research 
& Ethics Committee of the College of Medicine & 
Health Sciences at Sultan Qaboos University (MREC 
#672). Informed written consent was obtained from 
the parents or caregivers of all subjects before inclusion 
in the study.
Results
A total of eight OI patients with a mean age of 7.3 ± 
4.3 years were diagnosed and followed-up at SQUH 
during the study period. The male-to-female ratio 
was 3:5. Seven of these patients had OI type Ш while 
one had OI type IV. A total of 24 controls with a 
mean age of 6.9 ± 2.5 years were also included. The 
male-to-female ratio was 11:13. Both groups were 
proportionately similar in age and gender; however, 
there were significant differences in their height, 
weight and body surface area (BSA) [Table 1]. 
All of the OI patients had fractures and had been 
receiving pamidronate infusions every three months as 
part of their disease management plans. There was no 
evidence of systemic disease and none of the patients 
were taking other medications. The OI subjects were 
asymptomatic from a cardiac point of view and none 
had mitral or aortic valve regurgitation. None of the 
OI subjects had systemic hypertension and they were 
all in sinus rhythm. There was no electrocardiographic 
evidence of Wolff-Parkinson-White syndrome among 
any of the patients.
Standard two-dimensional echocardiography mea- 
surements and Z scores for both groups are reported 
in Table 2. Left ventricle and left atrium dimensions, 
aortic and pulmonary artery diameters and left 
ventricular systolic function data were not statistically 
significant between the two groups. However, when 
the left ventricular dimensions, aortic and pulmonary 
artery diameters were corrected for BSA, there was 
a statistically significant difference between the two 
groups. None of the subjects who had mild tricuspid 
valve regurgitation showed evidence of pulmonary 
hypertension (18.6 ± 1.4 mmHg [n = 7] versus 17.4 ± 
2.7 mmHg [n = 22]; P = 0.278) and the other subjects 
did not have echocardiographic evidence of elevated 
right ventricular pressure from assessment of the 
septal curvature and pulmonary valve regurgitation 
jet. Corrected IVRT for heart rate was comparable 
between the OI and control group (88.1 ± 17.4 ms 
versus 79.5 ± 11.9 ms; P = 0.125). Calculations of the Z 
score revealed that there was a statistically significant 
difference between the OI and the control group 
regarding aortic and pulmonary artery diameters. 
Regarding the left ventricular dimensions, the OI group 
had a larger Z score for the IVSd and LVPWd, but no 
significant difference was observed for the LVISd and 
LVIDd Z scores. None of the control subjects had a Z 
score of >2.
Other conventional and TDE assessment data 
are summarised in Table 3. There was a statistically 
significant decrease in the Em velocity for the OI 
group compared to the controls (84.8 ± 23.4 cm/s 
versus 103.4 ± 18.4 cm/s; P = 0.027). However, the 
Am and DTm measurements and Em/Am ratio were 
similar. A significant difference was observed in the 
TDE measurements of the lateral mitral valve and 
upper septum but with a comparable Em/E’m ratio 
and peak systolic velocity at all the measured sites. 
TDE measurements at the lateral tricuspid valve 
were similar between the two groups. Right upper 
pulmonary vein Doppler velocities and duration 
showed no statistically significant difference between 
the two groups with respect to Spv and Dpv peak 
velocities. However, a significant difference was 
observed for the Spv/Dpv ratio, peak a-wave reversal 
and duration. In contrast, there was a comparable Amd/
Apvd ratio for the OI and control subjects (1.6 ± 0.5 
versus 1.3 ± 0.4; P = 0.136). 
Multiple linear regression analysis showed that 
BSA was a significant predictor for LVIDd, LVISd, 
Khalfan S. Al-Senaidi, Irfan Ullah, Hashim Javad, Murtadha Al-Khabori and Saif Al-Yaarubi
Clinical and Basic Research | e459
Table 1: Characteristics of children with osteogenesis 
imperfecta in comparison to an age- and gender-
matched control group (N = 32)









Age in years 7.3 ± 4.3 6.9 ± 2.5 0.743
Height in cm 87.3 ± 24.9 124.0 ± 14.3 0.001
Weight in kg 15.0 ± 9.9 22.7 ± 7.4 0.025
BSA in m2 0.60 ± 0.28 0.89 ± 0.19 0.001
Systolic BP in 
mmHg
100.6 ± 5.0 103.4 ± 6.8 0.324
Diastolic BP in 
mmHg
57.1 ± 4.0 60.5 ± 5.0 0.136
Heart rate 
in beats per 
minute
105.5 ± 22.0 85.9 ± 17.0 0.054
QTc in ms 422.4 ± 11.0 418.4 ± 22.0 0.623
Haemoglobin 
in g/dL




0.4 (0.34‒0.40) 0.4 (0.35‒0.38) 0.717
Age started on 
pamidronate in 
months





54.5 ± 60.8 - -
SD = standard deviation; OI = osteogenesis imperfecta; BSA = body 
surface area; BP = blood pressure; QTc = QT interval corrected for 
heart rate; IQR = interquartile range.
Table 2: Echocardiographic measurements and Z scores 
of children with osteogenesis imperfecta in comparison 
to an age- and gender-matched control group (N = 32)
Measurement/Z 
score













LVIDd/BSA ratio 61.4 ± 13.6 44.1 ± 7.1 0.009
LVIDd Z score 0.7 ± 1.1 0.1 ± 0.8 0.080
LVISd in mm 20.0 ± 5.3 24.3 ± 3.6 0.065
LVISd/BSA ratio 37.4 ± 8.5 27.9 ± 3.9 0.015
LVISd Z score 0.4 ± 1.1 0.2 ± 0.7 0.441
IVSd in mm 6.5 ± 1.3 5.7 ± 1.0 0.151
IVSd/BSA ratio 12.7 ± 4.3 6.7 ± 1.8 0.005
IVSd Z score 1.4 ± 0.8 -0.1 ± 0.9 0.001







LVPWd/BSA ratio 10.7 ± 2.8 5.7 ± 1.6 0.001
LVPWd Z score 1.6 ± 0.3 -0.3 ± 0.8 0.001
EF in % 71.0 ± 4.2 66.4 ± 5.8 0.050
SF in % 39.1 ± 3.1 36.3 ± 4.6 0.068
AoAn in mm 14.8 ± 2.5 15.1 ± 1.8 0.680
AoAn/BSA ratio 28.5 ± 7.8 17.3 ± 2.0 0.005
AoAn Z score 2.9 ± 1.2 0.3 ± 0.5 0.001
SinVals in mm 18.6 ± 2.5 18.9 ± 2.7 0.793
SinVals/BSA ratio 36.6 ± 11.1 21.7 ± 2.6 0.007
SinVals Z score 1.8 ± 1.6 -0.5 ± 8.0 0.001
Sintubj in mm 16.9 ± 2.0 16.6 ± 2.3 0.786
Sintubj/BSA ratio 33.2 ± 10.5 19.1 ± 2.6 0.007
Sintubj Z score 2.4 ± 1.3 0.2 ± 0.7 0.001
AscAo in mm 17.3 ± 3.6 16.9 ± 2.2 0.758 
AscAo/BSA ratio 33.5 ± 11.6 19.4 ± 2.4 0.011
AscAo Z score 2.1 ± 2.3 -0.3 ± 1.0 0.001
PVAn in mm 15.4 ± 2.9 16.0 ± 2.8 0.570
PVAn/BSA ratio 29.4 ± 7.2 18.4 ± 2.8 0.003
PVAn Z score 1.6 ± 2.3 -0.7 ± 0.8 0.001
MPA in mm 16.4 ± 1.8 15.3 ± 2.1 0.189
MPA/BSA ratio 32.1 ± 9.6 17.7 ± 3.3 0.003
MPA Z score 1.2 ± 1.1 -1.1 ± 0.8 0.001
LPA in mm 11.5 ± 1.9 11.5 ± 1.1 0.941
LPA/BSA ratio 22.3 ± 6.0 13.5 ± 3.2 0.004
LPA Z score 2.7 ± 0.9 0.9 ± 0.8 0.001 
RPA in mm 11.9 ± 3.1 11.3 ± 1.2 0.473
RPA/BSA 22.3 ± 5.0 13.2 ± 2.6 0.001
RPA Z score 2.0 ± 0.7 0.0 ± 0.8 0.001
TVmax in mmHg 18.6 ± 1.4 (7)* 17.4 ± 2.7 (22)* 0.278
LA/AO ratio 1.4 ± 0.2 1.5 ± 0.2 0.315
IVRT in ms 67.5 ± 14.1 67.2 ± 11.2 0.946
Corrected IVRT† 
in ms 
88.1 ± 17.4 79.5 ± 11.9 0.125
SD = standard deviation; OI = osteogenesis imperfecta; LVIDd = left 
ventricular end diastolic dimension; IQR = interquartile range; BSA 
= body surface area; LVISd = left ventricular end systolic dimension; 
IVSd = interventricular septal dimension in diastole; LVPWd = left 
ventricular posterior wall dimension in diastole; EF = ejection fraction; 
SF = shortening fraction; AoAn = aortic valve annulus; SinVals = sinus 
of Valsalva; Sintubj = sinotubular junction; AscAo = ascending aorta; 
PVAn = pulmonary valve annulus; MPA = main pulmonary artery; 
LPA = left pulmonary artery; RPA = right pulmonary artery; TVmax 
= tricuspid valve regurgitation maximum peak velocity; LA/AO = 
left atrium aortic dimension ratio by M-mode; IVRT = isovolumic 
relaxation time.
*Number of subjects with mild tricusoid valve regurgitation and for 
whom TVmax could be measured. †Corrected for heart rate.
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IVSd, LVPWd, AoAn, AscAo and SinVals diameters 
(P = 0.01, 0.01, 0.04, 0.03, 0.01, 0.01 and 0.03, 
respectively). In comparison, OI was a significant 
predictor for IVSd, LVPWd, AoAn, SinVals and Sintubj 
(P = 0.03, 0.01, 0.04, 0.029 and 0.01, respectively). 
Systolic blood pressure was not a significant predictor 
for any of the tested independent variables [Table 4]. 
Discussion
In comparison to control subjects, there was 
significantly decreased peak early diastolic velocity and 
its ratio with the peak late diastolic velocity of the lateral 
mitral valve and upper septum among the studied 
group of OI patients. In addition, peak late diastolic 
velocity was significantly increased at the same sites 
among OI patients. Furthermore, the OI group had 
lower Em and lower peak a-wave reversal velocity and 
duration at the pulmonary vein. These findings indicate 
mild early changes in myocardial diastolic function; 
however, these changes are not considered as severe as 
those indicated by the Em/E’m and Amd/Apvd ratios, 
which were similar in the two groups. 
Migliaccio et al. compared adult OI patients with 
controls (n = 40 each) and observed a decrease in 
the Em velocity and Em/Am ratio with a significant 
increase in the IVRT and DTm.13 In the current study, 
pulmonary vein wave velocity data in OI patients 
compared to the control subjects showed a significant 
decrease in the a-wave reversal velocity and duration 
and an increase in the peak systolic and diastolic ratio. 
The likely explanation of such changes in OI patients 
is the greater stiffness of the myocardial tissue and 
decreased elasticity, leading to echocardiographic 
changes and altered myocardial relaxation.11 
While OI is primarily a bone disease, it presents 
with important extraskeletal abnormalities. Involve-
ment of the heart is due to an alteration in type 1 
collagen fibres.14 Myocardial collagen is primarily 
made up of collagen type 1, which contributes 
significantly to the myocardial and aortic wall strength 
and stiffness.15 Mutations in OI can directly alter the 
properties of collagen, either by decreasing synthesis 
or by altering functional and structural properties.16–18 
Such alterations in the collagen fibres could lead to 
the abnormalities seen in the myocardial and aortic 
wall echocardiographic parameters; this has been 
demonstrated in histological analyses of animal 
models.19–21 Radunovic et al. reported increased 
LVIDd, indexed aortic diameters for BSA and mitral 
and aortic regurgitation in OI adult patients compared 
to controls.22 The current study showed that left 
ventricular dimensions and wall thicknesses were 
similar between the two groups. However, the OI 
group had higher dimensions when corrected for BSA. 
Table 3: Tissue Doppler echocardiographic measurements of 
children with osteogenesis imperfecta in comparison to an age- 
and gender-matched control group (N = 32)






Em in cm/s 84.8 ± 23.4 103.4 ± 18.4 0.027
Am in cm/s 52.4 ± 20.9 50.9 ± 11.6 0.810
Em/Am ratio 1.8 ± 0.6 2.1 ± 0.4 0.156
Amd in ms 102.1 ± 21.7 110.9 ± 24.7 0.380
DTm in ms 130.6 ± 23.3 137.3 ± 22.9 0.485
Corrected DTm† 
in ms
169.4 ± 20.7 162.7 ± 26.3 0.519
S’m in cm/s 8.4 ± 1.9 8.8 ± 1.6 0.551
E’m in cm/s 14.4 ± 2.5 18.9 ± 2.8 0.001
A’m in cm/s 8.6 ± 2.2 6.7 ± 0.9 0.002
E’m/A’m ratio 1.8 ± 0.6 2.9 ± 0.4 0.002
Em/E’m ratio 6.1 ± 2.2 5.6 ± 1.3 0.484
Septum
Median S’s in 
cm/s (IQR)
7.0 (7.0‒8.5) 8.0 (7.25‒8.0) 0.204
E’s in cm/s 10.6 ± 1.7 14.9 ± 2.2 0.001
Median A’s in 
cm/s (IQR)
6.5 (6.0‒7.0) 6.0 (5.25‒8.0) 0.037
E’s/A’s ratio 1.6 ± 0.3 2.6 ± 0.54 0.001
Tricuspid valve
Median S’t in 
cm/s (IQR)
12.0 (7.5‒14.7) 12.0 (12.0‒13.0) 0.611
E’t in cm/s 14.5 ± 2.7 15.8 ± 1.8 0.141
A’t in cm/s 10.6 ± 2.9 10.1 ± 1.8 0.543
E’t/A’t ratio 1.4 ± 0.38 1.6 ± 0.45 0.217
Pulmonary vein
Spv in cm/s 52.9 ± 4.6 49.3 ± 8.9 0.288
Dpv in cm/s 51.6 ± 14.0 60.9 ± 11.9 0.080
Apv in cm/s 17.4 ± 3.4 21.1 ± 5.2 0.030
Apvd in ms 68.3 ± 18.4 88.7 ± 17.0 0.018
Spv/Dpv ratio 1.1 ± 0.3 0.8 ± 0.2 0.002
Amd/Apvd ratio 1.6 ± 0.5 1.3 ± 0.4 0.136  
SD = standard deviation; OI = osteogenesis imperfecta; Em = peak early mitral 
valve flow velocity; Am = peak late mitral valve flow velocity; 
Amd = Am duration; DTm = deceleration time of the Em wave; S’m = peak 
systolic velocity of the mitral valve; E’m = peak early diastolic velocity of the 
mitral valve; A’m = peak late diastolic velocity of the mitral valve; S’s = peak 
systolic velocity of the septum; IQR = interquartile range; E’s = peak early 
diastolic velocity of the septum; A’s = peak late diastolic velocity of the septum; 
S’t = peak systolic velocity of the tricuspid valve; E’t = peak early diastolic velocity 
of the tricuspid valve; A’t = peak late diastolic velocity of the tricuspid valve; Spv 
= peak systolic velocity of the pulmonary vein; Dpv = peak diastolic velocity of 
the pulmonary vein; Apv = peak a-wave reversal in the pulmonary vein; Apvd = 
peak a-wave reversal duration in the pulmonary vein.  †Corrected for heart rate. 
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This has been similarly reported in both adult and 
paediatric OI patients.7,13 
The incidence of mitral valve prolapse in OI is 
about 3–8%;6,7 however, none of the patients in the 
current study had mitral valve prolapse or aortic 
valve regurgitation. The studied subjects had normal 
systolic cardiac function and IVRT. There was no 
significant difference between the OI and control 
groups regarding the four aortic and pulmonary 
artery diameters. However, these diameters were 
significantly larger in the OI group compared to the 
control subjects when indexed for BSA. Moreover, 
regression analysis revealed that the diagnosis of OI 
was a significant predictor for larger left ventricular 
wall diameters in diastole and a larger diameter of the 
AoAn, SinVals and Sintubj. Karamifar et al. described 
aortic valve regurgitation in two out of 24 OI patients 
(8.3%).23 Radunovic et al. reported increased right 
ventricular outflow tract measurements and main 
pulmonary artery diameters in adult OI patients when 
indexed for BSA, indicating involvement of both the 
right and left sides of the heart.22 When the significant 
increase in the four pulmonary artery diameters were 
indexed to BSA and their Z scores were calculated, 
the findings of the current study were in line with 
the findings of Radunovic et al.22 The patients in the 
current study did not have any systemic illnesses, 
including hypertension or anaemia to confound the 
above changes. Moreover, none of the subjects had 
evidence of pulmonary hypertension.
This study highlights the need for detailed 
assessments of cardiac function in OI patients who are 
limited in their physical activities. Early therapeutic 
modalities could help to treat or modify the progression 
of the disease to prevent the deterioration of cardiac 
function. In order to draw a definitive conclusion, large-
scale, multicentre research is recommended to assess 
cardiovascular involvement in children with OI. As 
there are insufficient data available describing cardio-
vascular involvement in children with OI, patients in the 
current study will be followed-up and OI patients with 
altered diastolic parameters or great vessel dilation will 
be monitored. Patients with progressive aortic dilation 
may be prescribed beta blockers and angiotensin 
receptor blockers as both of these approaches have 
been suggested to prevent the progression of aortic root 
dilation in Marfan syndrome.24
This study was limited by its small sample size. 
Additionally, the patients were not symptomatic from a 
cardiac point of view and no normal values exist for the 
echocardiographic parameters in this particular group 
of patients. For this reason, age-matched controls were 
used for comparative purposes. It was not possible to 
perform further cardiac function assessments using 
two-dimensional speckle tracking as only limited 
echocardiographic views could be obtained due to 
Table 4: Simple regression analysis of left ventricular and four aortic dimensions of children with osteogenesis 
imperfecta in comparison to an age- and gender-matched control group (N = 32)
Dimension B regression coefficient 
(95% CI)
R2









































































































CI = confidence interval; OI = osteogenesis imperfecta; SBP = systolic blood pressure; DBP = diastolic blood pressure; BSA = body surface area; 
LVIDd = left ventricular end diastolic dimensions; LVISd = left ventricular end systolic dimensions; IVSd = interventricular septal thickness at 
diastole; LVPWd = left ventricular posterior wall thickness in diastole; AoAn = aortic annulus; SinVals = sinus of Valsalva; Sintubj = sinotubular 
junction; AscAo = ascending aorta. 
*In comparison to the control group. †P <0.05.
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chest deformities. Additionally, the echocardiographers 
performing the scans were not blinded to the study 
subjects, which may have introduced observer bias. As 
the majority of the OI subjects were diagnosed with 
type Ш OI, it was not possible to analyse the group of 
OI patients by disease subtype.
Conclusion
The paediatric OI subjects in the current study had 
normal systolic cardiac function and early changes 
in myocardial tissue Doppler velocities. This is 
suggestive of early diastolic cardiac dysfunction. 
Since these changes may worsen with time, careful 
cardiological evaluation and follow-up of these 
patients is warranted. Larger observational TDE 
studies assessing diastolic function in children with OI 
are recommended.
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